This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

HomeBrowseAboutFAQs
Log In
Sign Up
Postpartum Haemorrhage

Could Pre-operative Rectal Misoprostol Reduce Intra-operative Blood Loss During Ceserean Section?

Sponsored by Ain Shams University

About this trial

Last updated 9 years ago

Study ID

POMCS

Status

Completed

Type

Interventional

Phase

Phase 2/Phase 3

Placebo

No

Accepting

18-75 Years
18 to 40 Years
Female
Female

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 9 years ago

What is this trial about?

- Misoprostol reduces the uterine bleeding after cesarean delivery without harmful effects on either mother or baby. - The aim of the this study is to address if there is any benefits 'regarding the intra-operative blood loss' from preoperative rectal administration of 400 mic of Misoprostol in addition to the routinely administrated 10 units of oxytocin

What are the participation requirements?

Yes

Inclusion Criteria

- 38-41 weeks of amenorrhea

- scheduled for elective lower segment cesarean section

No

Exclusion Criteria

- confirmed intrauterine fetal death

- more than previous 2 ceserean sections

- multiple pregnancy

- antepartum haemorrhage

- self-reported maternal heart disease

- current diagnosis of severe malaria or acute bacterial infection